Paper32992829
To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity.
Pinski AN and 1 other. Microorganisms, 2020. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity. Papers, record 32992829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32992829
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References181
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12626527 | Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. | J Immunol | 2003 | https://conductscience.org/library/papers/12626527 | PubMed |
| 2 | 31774948 | Monoclonal Antibody Therapy for Ebola Virus Disease. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31774948 | PubMed |
| 3 | 20826752 | Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. | J Immunol | 2010 | https://conductscience.org/library/papers/20826752 | PubMed |
| 4 | 19440245 | Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. | PLoS One | 2009 | https://conductscience.org/library/papers/19440245 | PubMed |
| 5 | 8876140 | Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8876140 | PubMed |
| 6 | 21987745 | Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21987745 | PubMed |
| 7 | 29154144 | Multi-platform 'Omics Analysis of Human Ebola Virus Disease Pathogenesis. | Cell Host Microbe | 2017 | https://conductscience.org/library/papers/29154144 | PubMed |
| 8 | 21215658 | Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. | Immunity | 2011 | https://conductscience.org/library/papers/21215658 | PubMed |
| 9 | 18930776 | Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. | Vaccine | 2008 | https://conductscience.org/library/papers/18930776 | PubMed |
| 10 | 25171469 | Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. | Nature | 2014 | https://conductscience.org/library/papers/25171469 | PubMed |
| 11 | 23966302 | Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/23966302 | PubMed |
| 12 | 20587179 | Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. | Emerg Infect Dis | 2010 | https://conductscience.org/library/papers/20587179 | PubMed |
| 13 | 32738193 | A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition. | Cell Host Microbe | 2020 | https://conductscience.org/library/papers/32738193 | PubMed |
| 14 | 25589554 | Next-generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with vesicular stomatitis virus expressing Zaire Ebola virus glycoprotein (VSVΔG/EBOVgp). | Clin Vaccine Immunol | 2015 | https://conductscience.org/library/papers/25589554 | PubMed |
| 15 | 17942531 | Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. | J Virol | 2008 | https://conductscience.org/library/papers/17942531 | PubMed |
| 16 | 29123522 | Transcriptome Analysis of Circulating Immune Cell Subsets Highlight the Role of Monocytes in Zaire Ebola Virus Makona Pathogenesis. | Front Immunol | 2017 | https://conductscience.org/library/papers/29123522 | PubMed |
| 17 | 21178490 | Ebolavirus VP35 is a multifunctional virulence factor. | Virulence | 2010 | https://conductscience.org/library/papers/21178490 | PubMed |
| 18 | 31717793 | Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus. | Viruses | 2019 | https://conductscience.org/library/papers/31717793 | PubMed |
| 19 | 16698997 | Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. | J Virol | 2006 | https://conductscience.org/library/papers/16698997 | PubMed |
| 20 | 21987744 | Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21987744 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42623404 | Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings. | PLoS One | 2026 | https://conductscience.org/library/papers/42623404 | PubMed |
| 42376411 | Ebola virus disease: A persistent challenge in global health security. | Open Vet J | 2026 | https://conductscience.org/library/papers/42376411 | PubMed |
| 42324826 | The current landscape and future directions of Lyme disease vaccines. | Virulence | 2026 | https://conductscience.org/library/papers/42324826 | PubMed |
| 41599373 | The Emerging Promise of Pentacyclic Triterpenoid Derivatives as Novel Antiviral Agents Against SARS-CoV-2 Variants. | Molecules | 2026 | https://conductscience.org/library/papers/41599373 | PubMed |
| 41519695 | Access to licenced vaccines for high-threat infectious diseases: a scoping review and interpretive analysis of Ebola virus disease. | BMC Infect Dis | 2026 | https://conductscience.org/library/papers/41519695 | PubMed |
| 40157130 | Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40157130 | PubMed |
| 39585622 | In Vivo Investigation of Filovirus Glycoprotein-Mediated Infection in a BSL2 Setting. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/39585622 | PubMed |
| 39036089 | Vaccine adjuvants for infectious disease in the clinic. | Bioeng Transl Med | 2024 | https://conductscience.org/library/papers/39036089 | PubMed |
| 38745762 | A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients. | Innovation (Camb) | 2024 | https://conductscience.org/library/papers/38745762 | PubMed |
| 37514991 | Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/37514991 | PubMed |
| 36298451 | Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36298451 | PubMed |
| 35336165 | Hemorrhagic Fever Viruses: Pathogenesis and Countermeasures. | Microorganisms | 2022 | https://conductscience.org/library/papers/35336165 | PubMed |
| 34749265 | Therapeutic vaccination strategies against EBOV by rVSV-EBOV-GP: the role of innate immunity. | Curr Opin Virol | 2021 | https://conductscience.org/library/papers/34749265 | PubMed |
| 34484156 | Transcriptional Analysis of Infection With Early or Late Isolates From the 2013-2016 West Africa Ebola Virus Epidemic Does Not Suggest Attenuated Pathogenicity as a Result of Genetic Variation. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34484156 | PubMed |
| 34112056 | Distinct transcriptional responses to fatal Ebola virus infection in cynomolgus and rhesus macaques suggest species-specific immune responses. | Emerg Microbes Infect | 2021 | https://conductscience.org/library/papers/34112056 | PubMed |
Genes110
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32992829
GET https://conductscience.org/api/papers/v1/32992829/references?page=2